Back to search

Biopharm Services Limited

03656605

active
Private Limited Company
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Going concern doubt noted in accounts (-10)

Details

22 WYCOMBE END, BEACONSFIELD, HP9 1NB
Incorporated 27/10/1998

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

71122
Engineering related scientific and technical consulting activities

Officers

Mr Paul Andrew Sinclair

director · Since 27/10/1998

ENGINEER

BRITISH · ENGLAND · Age 69

Also on 1 other board

Persons with Significant Control

Mr Paul Andrew Sinclair

50–75% shares
50–75% votes

British · England · Age 69

22, Wycombe End, Beaconsfield, HP9 1NB

Notified 06/04/2016

CompanyRankvs 3281+ SIC 71122 peers
60

Financial strength99th percentile among SIC peers · 25/25
Employees97th percentile among SIC peers · 15/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements. Foreign currency Transactions in foreign currencies are recorded at the rate of exchange at the date of the

Key FinancialsYear ending 31/12/2024

Net Worth

£1.4M

Balance sheet strength

Cash

£666k

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

£76k

Fixed Assets

£56k

Debtors

£323k

10avg. employees-2
Prepared with Silverfin

EstimatesDerived

YearCurrent RatioImplied Profit
2024-£271k
20238.55+£1.7M
20229.98+£0
20218.10+£0
20205.03+£0
20197.06

Derived from filed accounts. Not audited figures.